Disorders of the thyroid gland in pregnancy

Czech version

Authors: A. Skřivánek ¹; M. Lubušký ^2,3; M. Studničková ²; I. Holusková ⁴; M. Procházka ²
Authors‘ workplace: G-Centrum Olomouc, vedoucí MUDr. A. Skřivánek ¹; Porodnicko-gynekologická klinika FN a LF UP, Olomouc, přednosta prof. MUDr. R. Pilka, Ph. D. ²; Ústav lékařské genetiky a fetální medicíny FN a LF UP, Olomouc, přednosta prof. MUDr. J. Šantavý, CSc. ³; Transfuzní oddělení FN a LF UP, Olomouc, primářka MUDr. D. Galuszková, MBA, Ph. D. ⁴
Published in: Ceska Gynekol 2013; 78(1): 99-106

Overview

Functional disorder of the thyroid gland affects individuals of all ages. Incidence and nature of the disease is influenced by supplying iodine, genetic and immunological factors and other external effects. Increased function occurs in 1–2% of the adult population, reduced function in the younger population diagnosed in about 5%, in women aged over 50 years we have beenat 10–15%. The incidence of thyroid diseases is higher in women than in men (5–8:1) and significantly increases with age. Approximately as common as overt forms of thyroid disease are their subclinical forms. Thyroid disease, especially asymptomatic reduction of function for direct examination is diagnosed up to 5% of pregnant women. Untreated decreased thyroid function of mothers may have significant negative impact on the course of pregnancy, as well as on fetal development, especially in the psychomotoric area. Women with the presence of antithyroid antibodies are at risk of pregnancy deepening malfunctions and/or postpartum thyroiditis. Czech Endocrinological Society currently pursuing a systematic screening of other risk population groups, including notably the pregnant and nursing women, women in old age and ill with some other disease or treatment with certain drugs.

Keywords:
hypothyroidism – pregnancy – thyrotropin – free thyroxine – triiodothyronine – antithyroidantibodies

Sources

1. Abalovich, M., Nobuyuki, A., Barbour, LA., et al. Clinical Practice Guideline. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Endocrinol Metab, 2007, 92(8 Suppl), S1–S47.

2. Alexander, EK., Marquesee, E., Lawrence, J., et al. Timing and magnitude of increases levothyroxine requirements during pregnancy in women with hypothyroidism. N Eng J Med, 2004, 351, p. 241–249.

3. Borovský, M., Lattáková, M. Štítna žľaza z pohľadu gynekológa. (The thyroid from the gynecologist’s point of view.) Prakt Gyn, 2007, 11, 4, s. 61–163.

4. Casey, BM., Dashe, JS., Spong, CY., et al. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstet Gynecol, 2007, 109, p. 1129–1135.

5. Casey, BM., Dashe, JS., Wells, CE., et al. Subclinical hypothyroidism and pregnancy outcome. Obstet Gynecol, 2005, 105, p. 239–245.

6. Glinoer, D., Solo, M., Bourdoux, P., et al. Pregnancy in patients with mild thyroid abnormalities: Maternal and neonatal repercusions. J Clin Endocrinol Metab, 1991, 73, p. 421–427.

7. Glinoer, D. Miscarriage in women with positive anti-TPO Antibodies: Is thyroxine the answer? J Clin Endocrinol Metabol, 2006, 91, 7, p. 2500–2502.

8. Haddow, JE,, McClain, MR., Lambert-Messerlian, G., et al. First and second trimester evaluation of risk for Fetal Aneuploidy Research Consortium: Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metabol, 2008, 93, 9, p. 3341–3347.

9. Haddow, JE., Palomaki, GE., Allan, WC., et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Eng J Med, 1999, 341, p. 549–555.

10. Jiskra, J., Límanová, Z., Potluková, E., Antošová, M. Význam screeningu tyreopatií u těhotných žen: patofyziologický podklad a praktické aspekty. (The importance of screening for thyroid dysfunction during pregnancy: pathophysiological background and practical implications.) Čas Lék čes, 2007, 146, 11, s. 827–833.

11. Kalvachová, B., Zamrazil, V. Štítná žláza v gynekologii a porodnictví – nové poznatky a praktické postupy. (Thyroid gland in gynecology and obstetrics. A new knowledge and practical approach.) Gynekolog, 2003, 12, 3, s. 104–108.

12. Klein, RZ., Sargent, JD., Larsen, PR., et al. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen, 2001, 8, p. 18–20.

13. Kořenek, A. Screening poruch štítné žlázy v graviditě a po porodu. (Screening of disturbances of thyroid gland during pregnancy and postpartum.) Prakt Gyn, 2009, 13, 3, s. 137–140.

14. Lazarus, JH. Thyroid disease in pregnancy and childhood. Minerva Endocrinol, 2005, 30, 2, p. 71–87.

15. Lazarus, JH., Premawardhana, LD. Screening for thyroid disease in pregnancy. J Clin Pathol, 2005, 58, 5, p. 449–452.

16. Lazarus, JH. Thyroid disorders associated with pregnancy: ethiology, diagnosis, and management. Treat Endocrinol, 2005, 4, 1, p. 31–41.

17. Liebert, MA. Iodine supplementation for pregnancy and lactation – US and Canada: recommendation of the American Thyroid Association. Thyroid, 2006, 16, p. 949–951.

18. Límanová, Z., Laňková, J., Zamrazil, V. Funkce štítné žlázy a těhotenství. Doporučený postup pro praktické lékaře „Funkční poruchy štítné žlázy“. 2008, s. 6.

19. Límanová, Z., Potluková, E. Význam preventivního vyšetření funkce štítné žlázy v graviditě. (Importance of active screening for thyroid disorders in pregnant women.) Čes Gynek, 2007, 11, 3, s. 120–124.

20. Límanová, Z., et al. Štítná žláza. Praha: Galén, 2006, 371 s.

21. Mitchell, ML., Klein, RZ. The sequelae of untreated maternal hypothyroidism. Eur J Endocrinol, 2004, 151, p. U45–U48.

22. Morreale de Escobar, G., Escobar, F. Maternal thyroid hormones early in pregnancy and fetal brain develompment. Best Pract Res Clin Endocrinol Metab, 2004, 18, p. 225–248.

23. Morreale de Escobar, G., Obregon, MJ., Escobar del Rey, F.Is neuropsychological development related to maternal hypothyroidism, or to maternal hypothyroxinaemia? J Clin Endocrinol Metab, 2000, 85, p. 3975–3987.

24. Negro, R., Formoso, G., Mangieri, T., et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab, 2006, 91, p. 2587–2591.

25. Negro, R., Formoso, G., Mangieri, T., et al. Euthyroid women with autoimmune thyroid disease undergoing the assistant reproduction technologies. The role of autoimmunity and thyroid function. J Clin Endocrinol Metabol, 2006, 91, p, 2587–2591.

26. Nohr, SB., Jorgensen, A., Pedersen, KM., et al. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-postitive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe? J Clin Endocrin Metab, 2000, 85, 9, p. 3191–3198.

27. Panesar, NS., Li, CY., Rogers, MS. Reference intervals for thyroid hormones in pregnant Chinese women. Ann Clin Biochem, 2001, 38, p. 329–332.

28. Pop, VJ., Kuijpens, JL., van Baar, AL., et al. Low maternal free thyroxine concentrations during early pregnancy are associatedwith impaired psychomotor development in infancy. Clin Endocrinol, 1999, 50, 2, p. 149–155.

29. Pop, VJ., Vulsma, T. Maternal hypothyroxinaemia during (early) gestation. Lancet, 2005, 365, 9471, p. 1604–1606.

30. Pop, VJ., Brouwers, EP., Vader, HL., et al. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol, 2003, 59, p. 282–288.

31. Pop, VJ., de Vries, E., van Baar, AL., et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab, 1995, 80, p. 3561–3566.

32. Poppe, K., Velkeniers, B., Glinoert, D. Thyroid disease and female reproduction. Clin Endocrinol, 2007, 66, p. 309–321.

33. Smallridge, RC., Ladenson, PW. Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab, 2001, 86, p. 2349–2353.

34. Soldin, OP., Tractenberg, RE., Hollowell, JG., et al. Trimester-specific changes in maternal thyroid hormone, thyrotropin, and thyroglobulin concentrations during gestation: trends and assciations across trimesters in iodine sufficeincy. Thyroid, 2004, 14, p. 1084–1090.

35. Soldin, OP., Soldin, D., Sastoque. M. Gestation specific thyroxine and thyroid stimulating hormone levels in the United States and worldwide. Therapeutic Drug Monitoring, 2007, 29, p. 553–559.

36. Springer, D., Límanová, Z., Zima, T., Calda, P. Vyšetření funkce štítné žlázy v těhotenství; naše výsledky. (Functional examination of maternal thyroid in pregnancy; our results.) Actual Gyn, 2009, 1, s. 50–54.

37. Springer, D., Zima, T., Limanova, Z. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy. Eur J Endocrinol, 2009, 160, 5, p. 791–797.

38. Springer, D., Horáček, J., Hauerová, D., Límanová, Z. Poruchy funkce štítné žlázy v těhotenství – souhrn výsledků nezávislých studií. (Thyroid malfunction in pregnancy.) Čes Gynek, 2007, 72, 6, p. 375–381.

39. Trávníček, T., a spol. Speciální patologická fyziologie. Praha: Avicenum, 1978, s. 387–396.

40. Vaidya, B., Anthony, S., Bilous, M., et al. Detection of thyroid dysfunction in early pregnancy: Universal screeing or targeted high risk case finding? J Clin Endocrinol Metab, 2007, 92, p. 203–207.

41. Vargová, V., Mechírová, V., Pytliak, M. Štítna žľaza v graviditě. (Tyhroid gland in the gravidity.) Čes Gynek, 2009, 74, s. 12–17.

42. Vermiglio, F., Lo Presti, VP., Moleti, M., et al. Attention deficit and hyperactivity disorders (ADHD) in the offsprings of mothers exposed to iodine deficiency. A possible novel iodine deficiency disorder in developed countries? J Clin Endocrinol Metab, 2004, 89, p. 6054–6060.